Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4(+) type 9 helper T cells and the VIP–VPAC2 signalling pathway

CONTEXT: Modified BuShenYiQi formula (M-BYF) is derived from BuShenYiQi formula, used for the treatment of allergic asthma. The exact effect and mechanism of M-BYF on the improvement of asthma remain unclear. OBJECTIVE: We investigated the mechanism underlying the therapeutic effect of M-BYF on alle...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Muhua, Wu, Jinfeng, Dong, Jingcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425750/
https://www.ncbi.nlm.nih.gov/pubmed/34493162
http://dx.doi.org/10.1080/13880209.2021.1970198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425750/
https://www.ncbi.nlm.nih.gov/pubmed/34493162
http://dx.doi.org/10.1080/13880209.2021.1970198

Ejemplares similares